EMEA-001019-PIP01-10-M05

Table of contents

Key facts

Invented name
Lonquex
Active substance
lipegfilgrastim
Therapeutic area
Oncology
Decision number
P/0034/2020
PIP number
EMEA-001019-PIP01-10-M05
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Prevention of chemotherapy-induced febrile neutropenia
  • Treatment of chemotherapy-induced neutropenia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
UAB "Sicor Biotech"

Tel. +44 (0)20 7540 7117
E-mail: med.info@tevapharm.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001019-PIP01-10-M05
Compliance opinion date
30/04/2020
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating